T1	Participants 144 234	patients with active rheumatoid arthritis and an inadequate response to methotrexate alone
T2	Participants 413 533	patients receiving a stable background regimen of methotrexate (MTX) who have an inadequate response to MTX monotherapy.
T3	Participants 590 623	patients with active RA (n = 507)
T4	Participants 1957 2031	In patients with active RA in whom the response to MTX has been inadequate
